Identification of prognostic claudins signature in hepatocellular carcinoma from a hepatocyte differentiation model
ConclusionsIn the present study, we developed a novel embryonic developmental claudins signature to monitor the extent of tumor dedifferentiation in HCC from an in vitro hepatocyte differentiation model. The claudins signature might present a great potential in predicting prognostic significance in HCC as cell surface biomarkers, and provide novel therapeutic targets for precision oncology further in the clinic.
Source: Hepatology International - Category: Infectious Diseases Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Genetics | Hepatocellular Carcinoma | Infectious Diseases | Liver | Liver Cancer | Stem Cell Therapy | Stem Cells | Study | Training | Universities & Medical Training | Urology & Nephrology